Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
arcticnovartis
- Shareholders approve 27th consecutive dividend increase to CHF 3.30 (+3.1%) per share for 2023; representing a 3.7% yield1 and approximately 58% payout of free cash flow
- Shareholders confirm Joerg Reinhardt as Chair of the Board of Directors as well as all other current members